Concepedia

Matthew J. Sheetz

MJ

Statistics

Publications

17

Citations

1.1K

H-Index

14

Active since

1988

Affiliations

Eli Lilly (United States)(Current)

Joslin Diabetes Center

Harvard University

University of Wisconsin–Madison

Eli Lilly (United Kingdom)

Matthew J. Sheetz is an author at Eli Lilly (United States) specializing in medicine, pharmacology, and liver physiology.

Top concepts

Publications per year

1988–2019

17

Publications

17

Anti–TGF-β1 Antibody Therapy in Patients with Diabetic Nephropathy

James R. Voelker, Paul H. Berg, Matthew J. Sheetz et al. · Journal of the American Society of Nephrology · 2016 · 264 citations

Splenomegaly in Dogs

Kenneth A. Johnson, B. E. Powers, S. J. Withrow et al. · Journal of Veterinary Internal Medicine · 1989 · 152 citations · Full text

ORAL PROTEIN KINASE C β INHIBITION USING RUBOXISTAURIN

Lloyd Paul Aiello, Louis Vignati, Matthew J. Sheetz et al. · Retina · 2011 · 96 citations

Effect of Ruboxistaurin on the Visual Acuity Decline Associated with Long-standing Diabetic Macular Edema

Matthew D. Davis, Matthew J. Sheetz, Lloyd Paul Aiello et al. · Investigative Ophthalmology & Visual Science · 2009 · 86 citations · Full text

, , +9

Targeting the hepcidin–ferroportin pathway in anaemia of chronic kidney disease

Matthew J. Sheetz, Philip Barrington, Sophie Callies et al. · British Journal of Clinical Pharmacology · 2019 · 73 citations · Full text

1–5 of 17